Newleos Therapeutics

Newleos Therapeutics company information, Employees & Contact Information

We are dedicated to providing a new dawn or "eos" for patients with mental health conditions by developing next generation, first- and best-in-class therapies. Over 100 million patients in the United States are affected by neuropsychiatric disorders, with anxiety and substance use disorders among the largest areas of unmet medical need. Our clinical-stage pipeline was licensed from Roche and includes oral small molecules targeting GABAA-γ1, V1a, TAAR1 and GABAA-α5 with broad potential in general anxiety, social anxiety, substance use disorders and cognitive impairment. Newleos was co-founded by Longwood Fund, Federico Bolognani, M.D., Ph.D., and William Martin, Ph.D., seasoned experts in company creation and CNS drug development.

Company Details

Employees
19
Founded
-
Address
800 Boylston St,
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Boston, Massachusetts
Looking for a particular Newleos Therapeutics employee's phone or email?

Newleos Therapeutics Questions

News

Newleos Therapeutics CEO David Donabedian Recognized by Goldman Sachs as One of the Most Exceptional Entrepreneurs at the 2025 Builders and Innovators Summit - Yahoo Finance

Newleos Therapeutics CEO David Donabedian Recognized by Goldman Sachs as One of the Most Exceptional Entrepreneurs at the 2025 Builders and Innovators Summit Yahoo Finance

Newleos Therapeutics Appoints Timothy Noyes as President and Chief Executive Officer - Business Wire

Newleos Therapeutics Appoints Timothy Noyes as President and Chief Executive Officer Business Wire

Newleos secures $93.5m for neuropsychiatric disorder treatments - Pharmaceutical Technology

Newleos secures $93.5m for neuropsychiatric disorder treatments Pharmaceutical Technology

Newleos Therapeutics Appoints Stephen Brannan To Board - citybiz

Newleos Therapeutics Appoints Stephen Brannan To Board citybiz

Newleos Therapeutics Announces Clinical Progress Across Neuropsychiatric Pipeline - Business Wire

Newleos Therapeutics Announces Clinical Progress Across Neuropsychiatric Pipeline Business Wire

Newleos Therapeutics Debuts with $93.5 Million Oversubscribed Series A Financing to Transform the Treatment of Neuropsychiatric Disorders through the Advancement of Novel Medicines - Yahoo Finance

Newleos Therapeutics Debuts with $93.5 Million Oversubscribed Series A Financing to Transform the Treatment of Neuropsychiatric Disorders through the Advancement of Novel Medicines Yahoo Finance

VC Longwood Fund unveils neuro biotech with $93M, assets licensed from Roche - Fierce Biotech

VC Longwood Fund unveils neuro biotech with $93M, assets licensed from Roche Fierce Biotech

A brain biotech launches with Roche’s spare parts - BioPharma Dive

A brain biotech launches with Roche’s spare parts BioPharma Dive

Newleos Therapeutics - The Pharma Letter

Newleos Therapeutics The Pharma Letter

Klein Hersh Recruits CEO for Newleos Therapeutics - Hunt Scanlon Media

Klein Hersh Recruits CEO for Newleos Therapeutics Hunt Scanlon Media

Newleos Raises $93.5M to Advance Neuropsychiatric Cast-Offs from Roche - BioSpace

Newleos Raises $93.5M to Advance Neuropsychiatric Cast-Offs from Roche BioSpace

Newleos Therapeutics Appoints Timothy Noyes as President & CEO - Contract Pharma

Newleos Therapeutics Appoints Timothy Noyes as President & CEO Contract Pharma

CEO changes at Basking, Newleos, Valitor, Mosaic, Generation Bio - BioCentury

CEO changes at Basking, Newleos, Valitor, Mosaic, Generation Bio BioCentury

Newleos Therapeutics names Timothy Noyes as president and CEO - The Pharma Letter

Newleos Therapeutics names Timothy Noyes as president and CEO The Pharma Letter

Newleos Therapeutics Expands Leadership Team to Advance its Clinical-Stage Neuropsychiatric Programs and Drive Corporate Growth - Business Wire

Newleos Therapeutics Expands Leadership Team to Advance its Clinical-Stage Neuropsychiatric Programs and Drive Corporate Growth Business Wire

Newleos Therapeutics Announces Clinical Advisory Board to Support Key Neuropsychiatry Programs - BioSpace

Newleos Therapeutics Announces Clinical Advisory Board to Support Key Neuropsychiatry Programs BioSpace

Newleos Therapeutics Raises $93.5M Series A - citybiz

Newleos Therapeutics Raises $93.5M Series A citybiz

Mental health startup Newleos debuts with $93.5M, clutch of Roche assets - FirstWord Pharma

Mental health startup Newleos debuts with $93.5M, clutch of Roche assets FirstWord Pharma

Novo Holdings invests USD 93.5m in biotech company focusing on anxiety - medwatch.com

Novo Holdings invests USD 93.5m in biotech company focusing on anxiety medwatch.com

J&J innovator vaults to Valo—Chutes & Ladders - Fierce Biotech

J&J innovator vaults to Valo—Chutes & Ladders Fierce Biotech

Top Newleos Therapeutics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant